CANARA ROBECO EMERGING EQUITIES (CREE)

Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
(as on August 30, 2024)


SCHEME OBJECTIVE To generate capital appreciation by investing in a diversified portfolio of large and mid-cap stocks. However, there can be no assurance that the investment objective of the scheme will be realized.
DATE OF ALLOTMENT March 11, 2005
BENCHMARK NIFTY Large Midcap 250 TRI
FUND MANAGER

Mr. Amit Nadekar
Mr. Shridatta Bhandwaldar

TOTAL EXPERIENCE 21 Years
15 Years
MANAGING THIS FUND Since 28-Aug-23
Since 01-Oct-19
ASSET ALLOCATION Large Cap equity and equity related instruments* - 35% to 65%. (Risk- Very High)
Mid Cap equity and equity related instruments* - 35% to 65% (Risk- Very High)
Other equity and equity related instruments, debt and money market instruments - 0% to 30% (Risk- Very High)
Reits/Invits- 0% to 10%.(Risk- Very High)
*As defined by SEBI Circular No. SEBI / HO / IMD / DF3 / CIR / P / 2017 / 114 dated October 06, 2017 and SEBI/HO/IMD/DF3/CIR/P/2017/126 dated December 04, 2017 as amended from time to time. (Currently it defines Large Cap Companies as those which are ranked from 1 to 100 and Mid Cap Companies as those which are ranked from 101 to 250 based on their full market capitalization.)
MINIMUM INVESTMENT ₹ 5000 and in multiples of ₹ 1 thereafter
Subsequent purchases: Minimum amount of ₹ 1000 and multiples of ₹ 1 thereafter
SIP: For Any date/monthly frequency – ₹ 1000 and in multiples of ₹ 1 thereafter
For quarterly frequency – ₹ 2000 and in multiples of ₹ 1 thereafter
STP: For Daily/Weekly/Monthly frequency – ₹ 1000 and in multiples of ₹ 1 thereafter
For quarterly frequency – ₹ 2000 and in multiples of ₹ 1 thereafter
SWP: For monthly frequency – ₹ 1000 and in multiples of ₹ 1 thereafter
For quarterly frequency – ₹ 2000 and in multiples of ₹ 1 thereafter
PLANS / OPTIONS Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal Option
Regular Plan - Payout of Income Distribution cum Capital Withdrawal Option
Regular Plan - Growth Option
Direct Plan - Reinvestment of Income Distribution cum Capital Withdrawal Option
Direct Plan - Payout of Income Distribution cum Capital Withdrawal Option
Direct Plan - Growth Option
ENTRY LOAD Nil
EXIT LOAD 1% - If redeemed/switched out within 1 year from the date of allotment
Nil - if redeemed/switched out after 1 year from the date of allotment
EXPENSE RATIO^:
Regular Plan : 1.59%
Direct Plan : 0.54%

Monthend AUM#
₹ 25,038.82 Crores
Monthly AVG AUM
₹ 24,305.63 Crores

(as on August 30, 2024) (₹)
Direct Plan - Growth Option
292.6200
Regular Plan - Growth Option
257.9000
Regular Plan - IDCW (payout/reinvestment
92.6200
Direct Plan - IDCW (payout/reinvestment)
139.6200

Standard Deviation
12.52
Portfolio Beta
0.88
Portfolio Turnover Ratio
0.66 times
R-Squared
0.92
Sharpe Ratio
0.91

Name of the Instruments
% to NAV

Equities

97.91

Listed

97.91

Banks

9.94

ICICI Bank Ltd

7.09

Federal Bank Ltd

2.39

State Bank of India

0.40

HDFC Bank Ltd

0.06

Automobiles

9.36

TVS Motor Co Ltd

3.19

Maruti Suzuki India Ltd

2.03

Tata Motors Ltd

1.53

Mahindra & Mahindra Ltd

1.21

Hero MotoCorp Ltd

1.00

Bajaj Auto Ltd

0.40

Auto Components

8.01

Uno Minda Ltd

4.48

Sona Blw Precision Forgings Ltd

1.28

Bharat Forge Ltd

1.12

Schaeffler India Ltd

0.66

ZF Commercial Vehicle Control Systems    India Ltd

0.47

Retailing

7.21

Trent Ltd

4.04

Zomato Ltd

2.16

Info Edge (India) Ltd

1.01

Consumer Durables

7.05

Dixon Technologies (India) Ltd

3.42

Crompton Greaves Consumer Electricals Ltd

1.17

Bata India Ltd

0.93

Titan Co Ltd

0.68

Cello World Ltd

0.55

Kajaria Ceramics Ltd

0.30

Leisure Services

6.38

Indian Hotels Co Ltd

4.47

EIH Ltd

1.49

Indian Railway Catering And Tourism Corp Ltd

0.42

IT - Software

5.71

KPIT Technologies Ltd

4.02

Tata Consultancy Services Ltd

1.69

Finance

5.48

Cholamandalam Investment and Finance  Co Ltd

3.51

Creditaccess Grameen Ltd

1.14

Bajaj Finance Ltd

0.83

Pharmaceuticals & Biotechnology

5.18

Abbott India Ltd

1.92

Sun Pharmaceutical Industries Ltd

1.28

Ajanta Pharma Ltd

0.69

Cipla Ltd

0.60

Dr. Reddy’s Laboratories Ltd

0.39

Natco Pharma Ltd

0.30

Aerospace & Defense

4.36

Bharat Electronics Ltd

4.36

Healthcare Services

3.67

Max Healthcare Institute Ltd

2.24

Global Health Ltd

0.90

Dr. Lal Path Labs Ltd

0.27

Apollo Hospitals Enterprise Ltd

0.26

Industrial Manufacturing

3.16

Praj Industries Ltd

2.25

Kaynes Technology India Ltd

0.91

Capital Markets

3.14

HDFC Asset Management Company Ltd

1.19

Central Depository Services (India) Ltd

1.00

Multi Commodity Exchange Of India Ltd

0.38

UTI Asset Management Co Ltd

0.30

Indian Energy Exchange Ltd

0.18

BSE Ltd

0.09

Transport Services

2.11

Interglobe Aviation Ltd

1.16

Blue Dart Express Ltd

0.44

TCI Express Ltd

0.26

Container Corporation Of India Ltd

0.25

Cement & Cement Products

1.96

Ultratech Cement Ltd

1.12

J.K. Cement Ltd

0.84

Telecom - Services

1.81

Bharti Airtel Ltd

1.81

Chemicals & Petrochemicals

1.77

Pidilite Industries Ltd

0.95

Vinati Organics Ltd

0.82

Agricultural Food & Other Products

1.65

Tata Consumer Products Ltd

1.65

Electrical Equipment

1.39

ABB India Ltd

1.39

Paper, Forest & Jute Products

1.39

Century Textile & Industries Ltd

1.39

Power

1.38

Torrent Power Ltd

1.38

Fertilizers & Agrochemicals

1.27

PI Industries Ltd

1.27

Beverages

1.19

United Breweries Ltd

1.07

Varun Beverages Ltd

0.12

Diversified

0.79

3M India Ltd

0.79

Realty

0.70

Oberoi Realty Ltd

0.70

Industrial Products

0.64

APL Apollo Tubes Ltd

0.64

Non - Ferrous Metals

0.53

Hindalco Industries Ltd

0.53

Construction

0.36

KNR Constructions Ltd

0.36

Entertainment

0.20

Zee Entertainment Enterprises Ltd

0.20

Gas

0.12

GAIL (India) Ltd

0.12

Insurance

0.00

Max Financial Services Ltd

0.00

Money Market Instruments

2.91

TREPS

2.91

Net Current Assets

-0.82

Grand Total ( Net Asset)

100.00

Canara Robeco Emerging Equities being an open ended large & mid cap fund, follows a bottom-up approach to predominantly invest in a well diversified portfolio of companies within large & mid cap universe. The fund endeavours to identify the stars of tomorrow within the segment.

This product is suitable for investors who are seeking*:
  • Capital appreciation over long term
  • Investing predominantly in equities and equity related instruments of both large cap and mid cap companies

Benchmark Riskometer
(NIFTY Large Midcap 250 TRI)
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

$ Source ICRA MFI Explorer | #Monthend AUM / Quantitative Information as on 30.8.2024 | ^The expense ratios mentioned for the schemes includes GST on investment management fees. Please click here for disclaimers.